Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes.

Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes. - Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042832

Enrollment

250

Registered

2020-12-25

Start date

2020-12-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with GDM between January 1 2015 and May 31 2020 at Yokohama Medical Center, and who had glucose tolerance test within postpartum period.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had; no measurement for insulin at the postpartum OGTT, been treated with steroid, or overt diabetes.

Design outcomes

Primary

Measure	Time frame
The risk factors for glucose intolerance in women with GDM during the postpartum period	—

Secondary

Measure	Time frame
1) Patient's basic information: age, pre-pregnancy BMI, and previous pregnancy 2) Gestational history of pregnancy and delivery: 75 g OGTT results, weight gain, number of days in pregnancy, maternal perinatal complications 3) Clinical information on the child: child weight, neonatal complications, and Apgar score 4) Treatment: insulin unit count 5) Postpartum information: postpartum 75gOGTT results 6) Patient's medical record information: Family history of diabetes	—

Measure

Time frame

1) Patient's basic information: age, pre-pregnancy BMI, and previous pregnancy 2) Gestational history of pregnancy and delivery: 75 g OGTT results, weight gain, number of days in pregnancy, maternal perinatal complications 3) Clinical information on the child: child weight, neonatal complications, and Apgar score 4) Treatment: insulin unit count 5) Postpartum information: postpartum 75gOGTT results 6) Patient's medical record information: Family history of diabetes

—

Countries

Japan

Contacts

Public ContactKazuki Tajima

Yokohama Medical Center Department of endocrinology & metabolism

tajima.kazuki.jn@mail.hosp.go.jp045-851-2621

Outcome results